Salivary levels of cortisol and chromogranin A in patients with burning mouth syndrome: A case-control study

Abstract

Burning mouth syndrome (BMS) is a poorly understood oral pain disorder characterized by a painful burning sensation in the oral cavity without any mucosal abnormalities. In this study, we evaluated the salivary cortisol and chromogranin A (CgA) levels of patients with BMS in comparison with age-matched controls. Subjects (n = 114) included 81 BMS patients and 33 controls. Patients with BMS were further classified into a subgroup of subjects who occasionally feel a burning sensation (BMS 1), and a subgroup of subjects who always feel a burning sensation (BMS 2). Salivary cortisol and CgA levels were measured using ELISA kits. All individuals with BMS had significantly higher cortisol and CgA levels than the controls did. Furthermore, when comparing the controls with each BMS subgroup, salivary levels of cortisol were significantly higher in both subgroups than controls. In contrast, the level of CgA was significantly higher in the BMS 2 subgroup only. Multiple regression analysis revealed a significant independent association between salivary levels of cortisol and BMS even after adjustment for gender, antidepressant or antianxiety drug use and hypertension (drug-treated). The study revealed that a significant association was observed between salivary cortisol levels and BMS.

Share and Cite:

Shigeyama-Haruna, C. , Soh, I. , Yoshida, A. , Awano, S. , Anan, H. and Ansai, T. (2013) Salivary levels of cortisol and chromogranin A in patients with burning mouth syndrome: A case-control study. Open Journal of Stomatology, 3, 39-43. doi: 10.4236/ojst.2013.31008.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Miriam, G. Joel, B.E. and Meir, G. (2002) Burning mouth syndrome. American Family Physician, 65, 615-620.
[2] Meir, G., Sol Jr., S. and Henry, C. (1991) Clinical characteristics and management outcome in the burning mouth syndrome. An open study of 130 patients. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 72, 192-195.
[3] Kitajima, S., Koga, C., Sakaino, H., Kameyama, T. and Takamuki, K. (2001) Changes in the character istics of dental psychosomatic patients visiting the department of oral surgery at a university hospital in Japan: A comparison of the clinical statistics collected in the course of treatment in 1989 and 1998. Japanese Journal of Psychosomatic Dentistry, 16, 43-49.
[4] Michele, D.M., Stefano, F., Lucio, L.R. and Stefania, L. (2005) The diagnosis of burning mouth syndrome represents a challenge for clinicians. Journal of Orofacial Pain, 19, 168-173.
[5] Scala, A., Checchi, L., Montevecch, M. and Marini, I. (2003) Update on burning mouth syndrome: Over view and patient management. Critical Reviews in Oral Biology and Medicine, 14, 275-291. doi:10.1177/154411130301400405
[6] George, P.C. and Philip, W.G. (1992) The consepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. The Journal of the American Medical Association, 267, 1244-1252. doi:10.1001/jama.1992.03480090092034
[7] Sally, S.D. and Margaret, E.K. (2004) Acute stressors and cortisol responses: A theoretical integration and synthesis of laboratory research. Psychopathologic Bulletin, 130, 355-391. doi:10.1037/0033-2909.130.3.355
[8] Daniel, T.O. and Keevin, N.B. (1984) Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. New England Journal of Medicine, 311, 764-770. doi:10.1056/NEJM198409203111204
[9] Saruta, J., Tukinoki, K., Sasaguri, K., Ishii, H., Yasuda, M., Osamura, Y., et al. (2005) Expression and localization of chromogranin A gene and protein in human submandibular gland. Cells Tissues Organs, 180, 237-244. doi:10.1159/000088939
[10] Shigeyama, C., Ansai, T., Awano, S., Soh, I., Yoshida, A., Hamasaki, T., et al. (2008) Salivary levels of cortisol and chromogranin A in patients with dry mouth compared with age-matched controls. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 106, 833-839. doi:10.1016/j.tripleo.2008.07.005
[11] Philip-John, L., Ruth, F., Sally-Anne, E., Caroline, P. and Terry, R. (2005) Vulnerability and presenting symptoms in burning mouth syndrome. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 99, 48-54. doi:10.1016/j.tripleo.2004.01.021
[12] Rojo, L., Silvestre, F.J., Bagan, J.V. and De Vicente, T. (1994) Prevalence of psychopathology in burning mouth syndrome. A comparative study among patients with and without psychiatric disorders and controls. Oral Surgery Oral Medicine Oral Pathology, 78, 312-316. doi:10.1016/0030-4220(94)90060-4
[13] Carlson, C.R., Miller, C.S. and Reid, K.I. (2000) Psychosocial profiles of patients with burning mouth syndrome. Journal of Orofacial Pain, 14, 59-64.
[14] Jose, M.A., Josiane, P., Juliana, B.H., Fernando, N.H., Denise, B., Francisco, L., et al. (2008) Anxiety and salivary cortisol levels in patients with burning mouth syndrome: Case-control study. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 105, 460-465. doi:10.1016/j.tripleo.2007.10.002
[15] Lopez-Jornet, P., Camacho-Alonso, F. and Andujar- Mateos, M.P. (2009) Salivary cortisol, stress, and quality of life in patients with burning mouth syndrome. Journal of European Dermatology Venereology, 23, 1197-1223.
[16] Toda, M., Den, R., Nagasawa, S., Kitamura, K. and Morimoto, K. (2005) Relationship between lifestyle scores and salivary stress markers cortisol and chromogranin A. Archives of Environmental and Occupational Health, 60, 266-269. doi:10.3200/AEOH.60.5.266-269
[17] Nakane, H., Asami, O., Yamada, Y., Harada, T., Matsui, N., Kanno, T., et al. (1998) Salivary chromogranin A as an index of psychosomatic stress response. Biomedical Research, 19, 410-406.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.